Open Access
Med Sci (Paris)
Volume 36, Number 1, Janvier 2020
Page(s) 24 - 26
Section Le Magazine
Published online 04 February 2020
  1. Valle-Casuso JC Angin M Volant S et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T cells and offers an opportunity to tackle infection. Cell Metab 2019 ; 29 : 611–626. [CrossRef] [PubMed] [Google Scholar]
  2. Roederer M Raju PA Mitra DK et al. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J Clin Invest 1997 ; 99 : 1555–1564. [CrossRef] [PubMed] [Google Scholar]
  3. Deeks SG Lewin SR Ross AL et al. International AIDS society: global scientific strategy towards an HIV cure. Nat Med 2012 ; 22 : 839–850. [Google Scholar]
  4. Heffern EF Ramani R Marshall G Kyei GB Identification of isoform-selective hydroxamic acid derivatives that potently reactivate HIV from latency. J Virus Erad 2019 ; 5 : 84–91. [PubMed] [Google Scholar]
  5. Zaikos TD Painter MM Sebastian Kettinger NT et al. Class 1-selective histone deacetylase (HDAC) inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression. J Virol 2018 ; 92 : 1–17. [Google Scholar]
  6. Xing Y Li A Yang Y et al. The regulation of FOXO1 and its role in disease progression. Life Sci 2018 ; 193 : 124–131. [CrossRef] [PubMed] [Google Scholar]
  7. Fabre S Lang V Harriague J et al. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol 2005 ; 174 : 4161–4171. [CrossRef] [PubMed] [Google Scholar]
  8. Nagashima T Shigematsu N Maruki R et al. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol 2010 ; 78 : 961–970. [CrossRef] [PubMed] [Google Scholar]
  9. Zou P Liu L Zheng L et al. Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle 2014 ; 13 : 3759–3767. [PubMed] [Google Scholar]
  10. Tanaka H Nagashima T Shimaya A et al. Effects of the novel FoxO1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice. Eur J Pharmacol 2010 ; 645 : 185–191. [CrossRef] [PubMed] [Google Scholar]
  11. Tan P Guan H Xie L et al. FOXO1 inhibits osteoclastogenesis partially by antagonizing MYC. Sci Rep 2015 ; 5 : 16835. [CrossRef] [PubMed] [Google Scholar]
  12. Chung S Lee TJ Reader BF et al. FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype. Oncotarget 2016 ; 7 : 17532–17546. [PubMed] [Google Scholar]
  13. Descours B Cribier A Chable-Bessia C et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells. Retrovirology 2012 ; 9 : 87. [CrossRef] [PubMed] [Google Scholar]
  14. Baldauf HM Pan X Erikson E et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med 2012 ; 18 : 1682–1687. [CrossRef] [PubMed] [Google Scholar]
  15. Lahouassa H Daddacha W Hofmann H et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012 ; 13 : 223–228. [CrossRef] [PubMed] [Google Scholar]
  16. Roux A Leroy H De Muylder B et al. FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction. PLoS Pathog 2019 ; 15 : 1–23. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.